Back to Search Start Over

Overview of Congenital Hepatic Fibrosis in Pediatrics: A Review

Authors :
Fahad Amrh AlAjmi
Khalid Mohammed A. Aladhadh
Ebtesam Ali S. Almadi
Naif Mohammed Al-Wagdani
Mansour Hemaid Alhelali
Nasser Naif Alsuhaymi
Ahmed Saeed S. Banheem
Sarah jamal Almujil
Ahmed Abdelsamie Fadl
Source :
Journal of Pharmaceutical Research International. :470-477
Publication Year :
2021
Publisher :
Sciencedomain International, 2021.

Abstract

Congenital hepatic fibrosis is a rare developmental illness caused by a ductal plate malformation, often known as ciliopathy or fibrocystic liver disease. Hepatosplenomegaly and portal hypertension are two symptoms. The disease affects 1/10000–20000 people. frequently associated with a variety of illnesses caused by genetic abnormalities, such as autosomal recessive polycystic kidney disease (ARPKD) and Caroli syndrome. There hasn't been a way to stop or reverse the progression of congenital hepatic fibrosis until now. Clinical trials of anti-fibrotic medicines such as colchicine, interferon gamma, angiotensin II receptor blockers, pirfenidone, and ursodeoxycholic acid found no significant benefit. The only known cure for CHF is liver transplantation, which is recommended when the condition has progressed to the point when symptoms of liver failure have appeared. In this article we will be making overview of the disease. It’s symptoms and diagnosis, different treatment method, and we will compare some of the articles published about the disease.

Details

ISSN :
24569119
Database :
OpenAIRE
Journal :
Journal of Pharmaceutical Research International
Accession number :
edsair.doi...........91926f849aa32d9a2330fc11dd736bcc
Full Text :
https://doi.org/10.9734/jpri/2021/v33i60a34507